(Q34309897)

1 August 2017

title

Torasemide: a pharmacoeconomic review of its use in chronic heart failure (English)

1 reference

1 August 2017

0 references

chronic heart failure

1 reference

M Young

1

1 reference

1 August 2017

G L Plosker

series ordinal

2

1 reference

1 August 2017

publication date

1 January 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

19

1 reference

1 August 2017

issue

6

1 reference

1 August 2017

page(s)

679-703

1 reference

Health economic consequences of the pharmacological treatment of heart failure

1 August 2017

cites work

1 reference

12 December 2020

Health care costs of heart failure: results from a randomised study of patient education

1 reference

12 December 2020

Acute and Long Term Effects of Loop Diuretics in Heart Failure

1 reference

12 December 2020

The treatment of heart failure: The Task Force of the Working Group on Heart Failure of the European Society of Cardiology

1 reference

12 December 2020

Torasemide. A review of its pharmacological properties and therapeutic potential

1 reference

12 December 2020

Inappropriate use of digoxin in the elderly: how widespread is the problem and how can it be solved?

1 reference

12 December 2020

Clinical pharmacology of loop diuretics

1 reference

12 December 2020

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

1 reference

12 December 2020

Predictors of readmission among elderly survivors of admission with heart failure

1 reference

12 December 2020

The pharmacoeconomics of ACE inhibitors in chronic heart failure

1 reference

12 December 2020

Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Effects of ACE inhibitors on heart failure in The Netherlands: a pharmacoeconomic model

1 reference

12 December 2020

Efficacy and safety of torasemide in patients with chronic heart failure

1 reference

12 December 2020

Torasemide. An update of its pharmacological properties and therapeutic efficacy

1 reference

12 December 2020

Epidemiology, aetiology, and prognosis of heart failure

1 reference

12 December 2020

Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management

1 reference

12 December 2020

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

12 December 2020

Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators.

1 reference

12 December 2020

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

1 reference

12 December 2020

Heart failure. A decision analytic analysis of New Zealand data using the published results of the SOLVD Treatment Trial. Studies of Left Ventricular Dysfunction

1 reference

12 December 2020

Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL study

1 reference

12 December 2020

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

12 December 2020

Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group

1 reference

12 December 2020

A pharmacoeconomic assessment of torsemide and furosemide in the treatment of patients with congestive heart failure

1 reference

12 December 2020

Interaction between nonsteroidal anti-inflammatory drugs and loop diuretics: modulation by sodium balance

1 reference

12 December 2020

Pharmacoeconomic comparison of loop diuretics in the treatment of congestive heart failure

1 reference

12 December 2020

The health care costs of heart failure in Sweden.

1 reference

12 December 2020

Determining the effectiveness of torasemide and furosemide in heart failure: design of a randomised comparison using the regenstrief medical record system

1 reference

12 December 2020

Pharmacodynamics of torsemide administered as an intravenous injection and as a continuous infusion to patients with congestive heart failure

1 reference

12 December 2020

Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group

1 reference

12 December 2020

Cost-effectiveness analysis in clinical practice: the case of heart failure

1 reference

12 December 2020

Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study

1 reference

12 December 2020

Cost of hospitalizations for heart failure: sodium retention versus other decompensating factors

1 reference

12 December 2020

Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy

1 reference

12 December 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

12 December 2020

Beneficial effects of metoprolol in heart failure associated with coronary artery disease: a randomized trial

1 reference

12 December 2020

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

1 reference

12 December 2020

Use of medical resources and quality of life of patients with chronic heart failure: a prospective survey in a large Italian community hospital

1 reference

12 December 2020

Healthcare costs of patients with heart failure treated with torasemide or furosemide

1 reference

12 December 2020

Benefits and risks of torasemide in congestive heart failure and essential hypertension

1 reference

12 December 2020

Sexual function in patients with advanced heart failure.

1 reference

12 December 2020

Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure)

1 reference

12 December 2020

Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.

1 reference

12 December 2020

Consensus recommendations for the management of chronic heart failure

1 reference

12 December 2020

Comparative pharmacodynamics of torasemide and furosemide in patients with oedema

1 reference

12 December 2020

Comparison of therapies with torasemide or furosemide in patients with congestive heart failure from a pharmacoeconomic viewpoint.

1 reference

12 December 2020

Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study

1 reference

12 December 2020

ABC of heart failure. History and epidemiology

1 reference

12 December 2020

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

1 reference

12 December 2020

Costs associated with symptomatic systolic heart failure

1 reference

12 December 2020

Clinical efficacy of torasemide, a new diuretic agent, in patients with acute heart failure: a double blind comparison with furosemide

1 reference

12 December 2020

Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group

1 reference

12 December 2020

Six-week study of torsemide in patients with congestive heart failure

1 reference

12 December 2020

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

1 reference

12 December 2020

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

12 December 2020

Diuretic therapy in elderly heart failure patients with and without left ventricular systolic dysfunction

1 reference

12 December 2020

Clinical and haemodynamic effects of long-term treatment with torasemide in congestive heart failure

1 reference

12 December 2020

Self-reported differences between cardiologists and heart failure specialists in the management of chronic heart failure

1 reference

12 December 2020

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

12 December 2020

Dose-response study of intravenous torsemide in congestive heart failure

1 reference

12 December 2020

Is the prognosis of heart failure improving?

1 reference

12 December 2020

The effect of digoxin on mortality and morbidity in patients with heart failure

1 reference

12 December 2020

Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.

1 reference

12 December 2020

The heart failure epidemic: exactly how big is it?

1 reference

12 December 2020

1 reference

12 December 2020

10.2165/00019053-200119060-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1023106195

0 references

Fatcat ID

release_fnxrjdtwxfh33bzbp45gukzlim

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fnxrjdtwxfh33bzbp45gukzlim

24 November 2022

mapped directly with Wikidata item

1 reference